#CNBCTV18Exclusive | NEGVAC head VK Paul says Govt is considering financial assistance for SII and Bharat Biotech. He also confirms a CNBC-TV18 newsbreak, says bridging trials can happen simultaneously with inoculations. #COVID19
Iran has reflected its needs to the Government and the Bharat Biotech. Happily, we have received the first consignment of 1,25,000 doses: Iran's Embassy in India on media queries on purchase of vaccines from India ~ANI
Iran has reflected its needs to the Government and the Bharat Biotech. Happily, we have received the first consignment of 1,25,000 doses: Iran's Embassy in India on media queries on purchase of vaccines from India
Bharat Biotech seeks govt permission to export its vaccine. Sources say that the co has sought govt nod to supply its #Vaccine to Iran, other countries to meet contractual obligations. @TimsyJaipuria has the details.
COVAXIN has demonstrated an interim vaccine efficacy of 81% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR: Bharat Biotech
We are not just conducting clinical trials in India. We have done clinical trials more than 12 countries including UK. We are doing clinical trials in Pakistan, Nepal, Bangladesh & other countries. We are not just an Indian company, we are truly a global company:Bharat Biotech MD
#NDTVExclusive | Shocking allegations by victims of Bhopal Gas Tragedy over trials of Bharat Biotech's Covid vaccine #Covaxin being conducted without proper, informed consent NDTV's Anurag Dwary reports
Covaxin has shown less than 10 % adverse reactions, while others have 60-70% adverse reactions.AstraZeneca was giving 4g paracetamol to volunteers to suppress such reactions. We haven’t given paracetamol to any volunteer. I can assure our vaccine is a 200 % safe:Bharat Biotech MD
Vaccines of Serum Institue of India and Bharat Biotech are granted permission for restricted use in emergency situation: DCGI
At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress.